- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03883841
Fetal Vascular Hemodynamic Changes in Iron Deficiency Anemia
March 19, 2019 updated by: Ahmed Mohamed Abbas, Assiut University
Fetal Vascular Hemodynamic Changes Before and After Treatment of Maternal Iron Deficiency Anemia
Iron deficiency anemia is a worldwide medical disorder.
So far, it is the most common medical complication in pregnancy specially in developing countries.
It is the cause of many adverse effects on mother and fetus and contributes significantly to high maternal mortality.
Maternal iron deficiency anemia is frequently associated with premature delivery, low birth weight babies
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
60
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
The study includes pregnant women 28 - 32 week gestation (calculated by the last menstrual period or by earlier ultrasound examination)
Description
Inclusion Criteria:
- Pregnant women with gestational age 28-32 weeks
- singleton pregnancy
- iron deficiency anemia.
Exclusion Criteria:
- Multiple pregnancy
- antepartum hemorrhage
- major congenital fetal anomalies
- any other type of anemia other than iron deficiency anemia
- any acute or chronic maternal disease other than iron deficiency anemia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study group
patients with iron deficiency anemia
|
intravenous infusion of iron sucrose
|
|
control group
normal pregnant patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The mean changes in middle cerebral artery Doppler of the fetus
Time Frame: one month
|
Doppler evaluation
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 1, 2019
Primary Completion (Anticipated)
August 1, 2020
Study Completion (Anticipated)
October 1, 2020
Study Registration Dates
First Submitted
March 19, 2019
First Submitted That Met QC Criteria
March 19, 2019
First Posted (Actual)
March 21, 2019
Study Record Updates
Last Update Posted (Actual)
March 21, 2019
Last Update Submitted That Met QC Criteria
March 19, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DIDA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron Deficiency Anemia
-
Children's Hospital Los AngelesNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingAnemia | Iron Deficiency Anemia | Anemia, Iron Deficiency | IDA - Iron Deficiency AnemiaUnited States
-
Pennington Biomedical Research CenterCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Tampere University HospitalTampere UniversityRecruitingIron Deficiency | Iron Deficiency Anaemia in Childbirth | Iron Status | Iron Deficiency in Pregnancy | Iron Deficiency Anemia in PregnancyFinland
-
Antalya Training and Research HospitalCompletedIron Deficiency Anemia | Iron Deficiency Anemia TreatmentTurkey
-
Ain Shams UniversityActive, not recruitingIron Deficiency Anemia TreatmentEgypt
-
Swiss Federal Institute of TechnologyUnited States Agency for International Development (USAID); Quadram Institute... and other collaboratorsCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)Peru
-
Arrowhead Regional Medical CenterRecruitingIron Deficiency Anemia of PregnancyUnited States
-
CMH Multan Institute of Medical SciencesCompletedPregnancy | Iron Deficiency Anemia (IDA)Pakistan
-
University of Lagos, NigeriaAminu Kano Teaching HospitalCompletedIron Deficiency Anemia of PregnancyNigeria
Clinical Trials on Iron Sucrose Solution for Injection
-
Imperial College LondonCompletedAnemia | Renal Failure Chronic
-
Sichuan Huiyu Pharmaceutical Co., LtdHenan (Zhengzhou) Zhonghui Cardiovascular Hospital; Changsha Duxact Biotechnology... and other collaboratorsCompletedSafety Issues | BioequivalencyChina
-
Sichuan Huiyu Pharmaceutical Co., LtdHenan (Zhengzhou) Zhonghui Cardiovascular Hospital; Changsha Duxact Biotechnology... and other collaboratorsCompletedSafety Issues | BioequivalencyChina
-
CN NGANOU-GNINDJIO, MD, MScCompletedIron Deficiency | Chronic Heart Failure (CHF)Cameroon
-
Xinhua Hospital, Shanghai Jiao Tong University...Completed
-
Ruijin HospitalCompletedLung Neoplasm | Segmentectomy;Intersegmental PlaneChina
-
Baxter Healthcare CorporationQuotient SciencesCompletedBioequivalanceUnited States
-
China-Japan Friendship HospitalRecruitingObesity | Anemia | Bariatric Surgery | Iron DeficienciesChina
-
American Regent, Inc.Completed
-
Watson PharmaceuticalsCompletedAnemia, Iron-Deficiency | Kidney Failure, ChronicUnited States, Puerto Rico